Regulatory Approval Expands Access to AI-Powered Diagnostics Across Latin America, Following FDA and CE Mark Clearances MILAN, Nov. 20, 2025 /PRNewswire/…
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a…
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a…
Veteran CFO appointment underscores the Company’s commitment to building a strong leadership team as it advances its clinical and commercial…
New lecanemab findings highlight the safety and potential benefits of subcutaneous administration for initiation dosing, the potential for additional long-term…
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…
GT-02287 reduces mitochondrial stress and enhances neuronal survival in MPP+ treated rat dopaminergic neurons GT-02287 decreases staining for MIRO1, suggesting…
OAKLAND, Calif., Nov. 19, 2025 /PRNewswire/ -- Today, educational software company Dynamoid announced the launch of the 10k Science immersive 3D…
NEW YORK, Nov. 19, 2025 /PRNewswire/ -- Expert Consumers has named Ka'Chava as the top tasting protein shake of 2025,…
Brain activity study shows Neuro-Contextual advertising drives 3.5x higher neural engagement and 26% lift in positive, action-driving response NEW YORK,…